Prof James Catto from the University of Sheffield described the findings as a "major breakthrough" in treating bladder cancer ...

According to Bladder Cancer UK, the main symptoms of bladder cancer are: ...

A specialist can diagnose bladder cancer using a variety of tests. “Bladder cancer can be diagnosed through a combination of ...

A “game-changer” study claims bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive. Patients with advanced ...

Invest in Arcus Biosciences for a strong buying opportunity with promising data, robust pipeline, and significant market ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...

Adding durvalumab and bevacizumab to transarterial chemoembolization improved responses and progression-free survival.

Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...